From Yahoo Finance: 2025-04-30 17:23:00

Global stocks remain attractive amid economic uncertainty, with ICON Public Limited Company (NASDAQ: ICLR) standing out as oversold. The company operates in 55 countries, offering clinical trial and research services to pharmaceutical firms. Despite industry challenges, ICLR’s bookings and backlog growth signal resilience and potential in the market.

ICON Public Limited Company (ICLR) posted Q4 2024 results in line with guidance, navigating industry headwinds. The company anticipates mid-year acceleration and aims for over $100 million in cost savings. ICLR prioritizes digital innovation and efficiency, positioning itself as a reliable player in the clinical research market.

ICLR ranks fourth among oversold global stocks favored by hedge funds. While the company shows promise, AI stocks may offer higher returns in a shorter timeframe. An AI stock has surged in 2025, outperforming popular options by 25%. Consider exploring AI stocks for potential gains.

Read more: Is ICON Public Limited (ICLR) One of the Oversold Global Stocks to Buy According to Hedge Funds?